AAPL   321.77 (-1.03%)
MSFT   183.54 (-0.99%)
FB   226.99 (-1.38%)
GOOGL   1,417.59 (-1.50%)
AMZN   2,463.00 (-0.62%)
NVDA   350.60 (-0.05%)
BABA   218.39 (-0.10%)
MU   51.27 (+4.80%)
GE   7.64 (+3.80%)
TSLA   869.05 (-1.58%)
T   31.59 (+0.22%)
F   6.47 (+4.52%)
GILD   77.83 (+4.61%)
DIS   123.14 (+0.78%)
NFLX   412.86 (-2.16%)
BAC   26.57 (+2.23%)
BA   186.35 (+7.62%)
AAPL   321.77 (-1.03%)
MSFT   183.54 (-0.99%)
FB   226.99 (-1.38%)
GOOGL   1,417.59 (-1.50%)
AMZN   2,463.00 (-0.62%)
NVDA   350.60 (-0.05%)
BABA   218.39 (-0.10%)
MU   51.27 (+4.80%)
GE   7.64 (+3.80%)
TSLA   869.05 (-1.58%)
T   31.59 (+0.22%)
F   6.47 (+4.52%)
GILD   77.83 (+4.61%)
DIS   123.14 (+0.78%)
NFLX   412.86 (-2.16%)
BAC   26.57 (+2.23%)
BA   186.35 (+7.62%)
AAPL   321.77 (-1.03%)
MSFT   183.54 (-0.99%)
FB   226.99 (-1.38%)
GOOGL   1,417.59 (-1.50%)
AMZN   2,463.00 (-0.62%)
NVDA   350.60 (-0.05%)
BABA   218.39 (-0.10%)
MU   51.27 (+4.80%)
GE   7.64 (+3.80%)
TSLA   869.05 (-1.58%)
T   31.59 (+0.22%)
F   6.47 (+4.52%)
GILD   77.83 (+4.61%)
DIS   123.14 (+0.78%)
NFLX   412.86 (-2.16%)
BAC   26.57 (+2.23%)
BA   186.35 (+7.62%)
AAPL   321.77 (-1.03%)
MSFT   183.54 (-0.99%)
FB   226.99 (-1.38%)
GOOGL   1,417.59 (-1.50%)
AMZN   2,463.00 (-0.62%)
NVDA   350.60 (-0.05%)
BABA   218.39 (-0.10%)
MU   51.27 (+4.80%)
GE   7.64 (+3.80%)
TSLA   869.05 (-1.58%)
T   31.59 (+0.22%)
F   6.47 (+4.52%)
GILD   77.83 (+4.61%)
DIS   123.14 (+0.78%)
NFLX   412.86 (-2.16%)
BAC   26.57 (+2.23%)
BA   186.35 (+7.62%)
Log in

NASDAQ:IMGNImmunoGen Price Target & Analyst Ratings

$4.74
+0.01 (+0.21 %)
(As of 06/4/2020 02:48 PM ET)
Add
Compare
Today's Range
$4.56
Now: $4.74
$4.88
50-Day Range
$3.40
MA: $4.27
$5.34
52-Week Range
$1.81
Now: $4.74
$7.07
Volume71,524 shs
Average Volume2.36 million shs
Market Capitalization$826.70 million
P/E RatioN/A
Dividend YieldN/A
Beta2.31

Analyst Ratings

ImmunoGen (NASDAQ:IMGN) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
4 Wall Street analysts have issued ratings and price targets for ImmunoGen in the last 12 months. Their average twelve-month price target is $10.50, suggesting that the stock has a possible upside of 121.52%. The high price target for IMGN is $12.00 and the low price target for IMGN is $9.00. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldHold
Consensus Rating Score: 2.752.602.202.13
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $10.50$7.98$5.97$3.28
Price Target Upside: 121.52% upside112.80% upside37.56% upside43.23% upside

ImmunoGen (NASDAQ:IMGN) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

ImmunoGen (NASDAQ:IMGN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/1/2020HC WainwrightReiterated RatingBuy$9.00Low
5/14/2020Canaccord GenuityReiterated RatingBuy$12.00High
12/10/2019CowenReiterated RatingBuyLow
9/24/2019SVB LeerinkReiterated RatingHoldMedium
5/15/2019GuggenheimDowngradeBuy ➝ NeutralHigh
3/19/2019JPMorgan Chase & Co.DowngradeNeutral ➝ UnderweightHigh
3/5/2019Morgan StanleyUpgradeUnderweight ➝ Equal Weight$2.68Low
3/1/2019Jefferies Financial GroupDowngradeBuy ➝ HoldHigh
3/1/2019Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$13.00 ➝ $2.50High
10/22/2018William BlairReiterated RatingOutperformHigh
4/8/2018Cantor FitzgeraldSet Price TargetHold$5.00Low
3/21/2018Royal Bank of CanadaBoost Price TargetOutperform$16.00Low
(Data available from 6/4/2018 forward)
This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.